iScience (Sep 2022)

Fetal sex-specific epigenetic associations with prenatal maternal depressive symptoms

  • Michelle Z.L. Kee,
  • Ai Ling Teh,
  • Andrew Clappison,
  • Irina Pokhvisneva,
  • Julie L. MacIssac,
  • David T.S. Lin,
  • Katia E. Ramadori,
  • Birit F.P. Broekman,
  • Helen Chen,
  • Mary Lourdes Daniel,
  • Neerja Karnani,
  • Michael S. Kobor,
  • Peter D. Gluckman,
  • Yap Seng Chong,
  • Jonathan Y. Huang,
  • Michael J. Meaney

Journal volume & issue
Vol. 25, no. 9
p. 104860

Abstract

Read online

Summary: Prenatal maternal mental health is a global health challenge with poorly defined biological mechanisms. We used maternal blood samples collected during the second trimester from a Singaporean longitudinal birth cohort study to examine the association between inter-individual genome-wide DNA methylation and prenatal maternal depressive symptoms. We found that (1) the maternal methylome was significantly associated with prenatal maternal depressive symptoms only in mothers with a female fetus; and (2) this sex-dependent association was observed in a comparable, UK-based birth cohort study. Qualitative analyses showed fetal sex-specific differences in genomic features of depression-related CpGs and genes mapped from these CpGs in mothers with female fetuses implicated in a depression-associated WNT/β-catenin signaling pathway. These same genes also showed enriched expression in brain regions linked to major depressive disorder. We also found similar female-specific associations with fetal-facing placenta methylome. Our fetal sex-specific findings provide evidence for maternal-fetal interactions as a mechanism for intergenerational transmission.

Keywords